亿帆医药(002019.SZ)：易黄汤颗粒收到药品注册受理通知书

Core Viewpoint - Yifan Pharmaceutical (002019.SZ) has received a registration acceptance notice from the National Medical Products Administration for its product Yihuang Decoction Granules, marking a significant step in its product development strategy [1] Group 1: Product Development - Yifan Pharmaceutical's wholly-owned subsidiary, Suzhou Yifan Pharmaceutical Co., Ltd., received the registration acceptance notice on January 6, 2026 [1] - Yihuang Decoction Granules is the first classic formula product registered by the company, based on a prescription from the "First Batch of Ancient Classic Formulas Catalog" published by the National Administration of Traditional Chinese Medicine in April 2018 [1] - The formula is derived from the Qing Dynasty work "Fu Qingzhu Nüke" by Fu Shan, and is indicated for treating kidney deficiency with damp-heat symptoms [1] Group 2: Indications and Usage - The primary function of Yihuang Decoction Granules is to solidify the kidney and stop abnormal discharge, as well as to clear heat and eliminate dampness [1] - It is specifically used for symptoms such as excessive, thick, yellow discharge resembling concentrated tea, with a foul odor, red tongue, and yellow greasy coating [1]